Fibromuscular dysplasia: Difference between revisions

Jump to navigation Jump to search
Line 2: Line 2:
{{Fibromuscular dysplasia}}
{{Fibromuscular dysplasia}}


'''For patient information page, click [[{{PAGENAME}} (patient information)|here]]'''
'''Fo patient information page, click [[{{PAGENAME}} (patient information)|here]]'''


{{CMG}}; '''Associate Editor-in-Chief:''' {{M.B}}
{{CMG}}; '''Associate Editor-in-Chief:''' {{M.B}}
Line 16: Line 16:


== [[Fibromuscular dysplasia historical perspective|Historical Perspective]] ==
== [[Fibromuscular dysplasia historical perspective|Historical Perspective]] ==
Fibromuscular dysplasia was first discovered by Leadbetter and Burkland, in 1938 following evaluation of severe hypertension in a 5-year-old boy. The first histopathological description of fibromuscular dysplasia and pathologic classification for this condition was proposed in 1958 and 1971 by McCormack and coworkers.
Fibromuscular dysplasia with involvement of extrarenal [[arteries]] has been considering in recent years. However numerous aspects of [[molecular biology]] ang [[genetic]] [[etiology]] of this condition remains unanswered, and there are various top research priorities in the field of FMD to improve our understanding of this condition.


== [[Fibromuscular dysplasia pathophysiology|Pathophysiology]] ==
== [[Fibromuscular dysplasia pathophysiology|Pathophysiology]] ==
* In Fibromuscular dysplasia, the proliferation of [[vascular smooth muscle]] of one or more small or medium-sized [[arteries]] undergo [[dysplasia]] and cause [[stenosis]]. this [[abnormal]] [[cellular]] [[development]] is characterized by [[fibrous]] thickening of the [[Tunica intima|intima]], [[Tunica media|media]], or [[adventitia]] of the involved arteries; which ultimately lead to arterial narrowing.


== [[Fibromuscular dysplasia causes|Causes]] ==
== [[Fibromuscular dysplasia causes|Causes]] ==
Line 26: Line 30:


== [[Fibromuscular dysplasia risk factors|Risk Factors]] ==
== [[Fibromuscular dysplasia risk factors|Risk Factors]] ==
There are no established risk factors for fibromuscular dysplasia; neverteless there are evidences that [[cigarette smoking]], [[hypertension]] and other classic risk factors for [[atherosclerosis]] may be risk factors in the development of FMD .
However FMD has a greater [[prevalence]] among women but no definite association has been
found between this condition and use of [[Oral contraceptive|oral contraceptives]] or disturbances of [[Sex hormones|endogenous sex hormones]].
Since the disease is more common among the first-degree relatives of patients with FMD, Genetic factors may play a role in the development of FMD.dysplasia,


== [[Fibromuscular dysplasia natural history, complications and prognosis|Natural History, Complications and Prognosis]] ==
== [[Fibromuscular dysplasia natural history, complications and prognosis|Natural History, Complications and Prognosis]] ==

Revision as of 03:19, 27 July 2018

Fibromuscular dysplasia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Fibromuscular dysplasia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiorgram

X-ray

CT

MRI

Arteriography

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Management Guidelines

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

ASA/ACCF/AHA Guideline Recommendations

Management of Patients With Fibromuscular Dysplasia of the Extracranial Carotid Arteries

Case Studies

Case #1

Fibromuscular dysplasia On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Fibromuscular dysplasia

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Fibromuscular dysplasia

CDC on Fibromuscular dysplasia

Fibromuscular dysplasia in the news

Blogs on Fibromuscular dysplasia

Directions to Hospitals Treating Fibromuscular dysplasia

Risk calculators and risk factors for Fibromuscular dysplasia

Fo patient information page, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-in-Chief: Mohsen Basiri M.D.

Synonyms and keywords: FMD

Overview

The definition of Fibromuscular Dysplasia(FMD) on the Medical Subject Headings is "an idiopathic, segmental, nonatheromatous disease of the musculature of arterial walls, leading to stenosis of small and medium-sized arteries. There is a true proliferation of smooth muscle cells and fibrous tissue formation. however, this systemic arteriopathy is a noninflammatory process and is therefore not associated with inflammatory biomarkers.

According to the definition, FMD is a condition which can involve every vascular bed in the body, therefore it can cause very heterogeneous and extensive spectrum of clinical manifestations from asymptomatic involvement to devastating consequences and morbidity and mortality.

Unlike routine conception that FMD is a rare disease of middle-aged female, current data from the French and US registries showed that the awareness about FMD must be raised, and every health provider at any level should be familiar with suggestive symptoms and signs of FMD which is more frequent and more often systematic than previously thought.

Historical Perspective

Fibromuscular dysplasia was first discovered by Leadbetter and Burkland, in 1938 following evaluation of severe hypertension in a 5-year-old boy. The first histopathological description of fibromuscular dysplasia and pathologic classification for this condition was proposed in 1958 and 1971 by McCormack and coworkers.

Fibromuscular dysplasia with involvement of extrarenal arteries has been considering in recent years. However numerous aspects of molecular biology ang genetic etiology of this condition remains unanswered, and there are various top research priorities in the field of FMD to improve our understanding of this condition.

Pathophysiology

Causes

Differentiating Fibromuscular dysplasia from other Diseases

Epidemiology and Demographics

Risk Factors

There are no established risk factors for fibromuscular dysplasia; neverteless there are evidences that cigarette smoking, hypertension and other classic risk factors for atherosclerosis may be risk factors in the development of FMD .

However FMD has a greater prevalence among women but no definite association has been

found between this condition and use of oral contraceptives or disturbances of endogenous sex hormones.

Since the disease is more common among the first-degree relatives of patients with FMD, Genetic factors may play a role in the development of FMD.dysplasia,

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | CT | MRI | Arteriography | Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Management Guidelines | Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

de:Fibromuskuläre Dysplasie

Template:WH Template:WS